News und Analysen
Eine neu veröffentlichte multizentrische RCT zeigt, dass Smith+Nephew PICO◊ sNPWT kanisterlose Unterdruck-Wundtherapie herkömmlicher tNPWT bei der Reduzierung von Wundfläche, -tiefe und -volumen bei DFU und UCV überlegen ist
Smith+Nephew (LSE:SN, NYSE:SNN), das globale Medizintechnikunternehmen, freut sich, die Veröffentlichung von Ergebnissen aus einer neuen randomisierten kontrollierten klinischen Studie (RCT)
Clinical trial demonstrated superior wound closure rates with PICO◊ compared to traditional NPWT in lower extremity ulcers1
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the publication of a new randomized controlled trial (RCT) which demonstrated that the use of PICO Single
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc